Physicochemical and in vitro characterization of Agarose based nanocarriers incorporated with Graphene Quantum Dots/ α-Fe2O3 for targeted drug delivery of Quercetin to liver cancer treatment
Mohammad Najafi,Zahra Khoddam,Mobina Masnavi,Mehrab Pourmadadi,Majid Abdouss
DOI: https://doi.org/10.1016/j.matchemphys.2024.129333
IF: 4.778
2024-05-06
Materials Chemistry and Physics
Abstract:The forefront hydrogel nanocomposite, resulting from the integration of Agarose (Aga), Graphene Quantum Dots (GQDs), and α-Fe2O3, offers a novel approach to pH-responsive drug delivery, specifically tailored for the controlled release of Quercetin (QC), a potent anti-cancer agent. The incorporation of the surfactant Span 80 enhances the unique properties conferred by the integration of α-Fe2O3 into the Aga-modified GQDs hydrogel, resulting in the production of stable nanocarriers that improve QC retention. Thorough analyses utilizing Fourier-transform Infrared Spectroscopy (FT-IR) and X-ray Diffraction (XRD) shed light on the characteristics of the nanocarriers. The presence of nanoparticles within the nanocarriers was confirmed by Dynamic Light Scattering (DLS), revealing a spherical morphology with an average size of approximately 279.04 nm and a polydispersity index (PDI) of 0.24. Measurements of the zeta potential indicated a positive surface charge of about 52.8 mV. In the Aga/GQDs configuration, loading and encapsulation efficiencies reached 35% and 67%, respectively. With the inclusion of α-Fe2O3, improvements were observed, with loading and encapsulation efficiencies reaching 47% and 86.25%, respectively, surpassing previous values. Cellular tests conducted on the HepG2 cell line demonstrated the heightened anticancer efficacy of QC-loaded nanoparticles while assessing potential adverse effects. These results underscore the exciting potential of the nanocarrier as a promising strategy for cancer treatment.
materials science, multidisciplinary